WEBSITECHANGES

Website Changes

---

02/09/2017

Trials Open for Enrollment: Phase II Study of VAL-083 in Patients with MGMT-unmethylated Bevacizumab-naïve Recurrent Glioblastoma Multiforme

---

02/07/2017

DelMar Pharmaceuticals Inc (DMPI) Moves Forward With Flagship Chemotherapy Into Phase II

---

02/06/2017

NW Bio Announces Lifting of Clinical Hold on DCVax®-L Phase III Trial By FDA

---

02/04/2017

17th Annual UCLA Brain Tumor Conference

---

02/04/2017

Optimism and Opportunity as we Initiate Clinical Trials for MGMT-unmethylated GBM Patients at MD Anderson

---

02/04/2017

Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease

---

02/04/2017

FDA Grants New Clearance for Brain Surgery Technology

---

02/04/2017

Northwell Health is First on Long Island to Acquire Synaptive Medical’s BrightMatter™ Technology for Complex Brain Tumor and Spinal Surgery

---

02/04/2017

Researchers at Yale have taken steps toward a ‘completely unexpected’ new way to treat brain cancer

---

02/04/2017

New Brain Cancer Coalition Announces Precision Medicine Study During CHOP Event

---

01/28/2017

The Musella Foundation announced that it has awarded a $25,000 brain tumor research grant

---

01/26/2017

Out of Warburg Effect: an effective cancer treatment targeting the tumor specific metabolism and dysregulated pH.

---

01/25/2017

Correction to: Brain Surgery Made Safer With New Smart Needle

---

01/25/2017

DelMar Pharmaceuticals and MD Anderson Initiate New Phase Two Clinical Trial of VAL-083 for MGMT-unmethylated Recurrent Glioblastoma Multiforme (GBM)

---

01/25/2017

‘Tumor Shrinking’ Drug Shows Promise In Dogs Before Clinical Trials On Humans

---

01/25/2017

Antiangiogenic treatments prolong OS in glioblastoma subgroup

---

01/25/2017

Combination therapy for glioblastoma shows promising results in early-stage research

---

01/24/2017

Norton, UK Partner on Clinical Trial for First-Ever Treatment of Radiation Necrosis

---

01/24/2017

Quick Survey For GBM patients

---

01/24/2017

Brain Surgery Made Safer With New Smart Needle

---

01/23/2017

The Musella Foundation announced that it has awarded a $10,000 brain tumor research grant

---

01/23/2017

Musella Foundation Request for Brain Tumor Research Grant Proposals

---

01/19/2017

Musella Foundation Copayment Assistance Program is now closed to new patients

---

01/19/2017

Agenus announces collaboration with the National Cancer Institute to evaluate the combination of Pembrolizumab (Keytruda®, Merck & Co., Inc.) with Prophage™ (Agenus Inc.) autologous vaccine

---

01/19/2017

New Study Aims to Extend TTFields Beyond Grade IV Brain Cancer Domain

---